Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials

Overview of attention for article published in BMC Cancer, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 2 news outlets
twitter: 1 X user

reddit: 1 Redditor

Readers on

mendeley: 25 Mendeley

Summary News X Reddit

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials https://t.co/924Nq5ClnP #lungcancer #oncology https://t.co/itzgO5TnyA

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.